Promising new treatment for pancreatic cancer doubles survival rates
By — Stephanie Sy Stephanie Sy By — Karina Cuevas Karina Cuevas By — Katie Marlow Katie Marlow Leave your feedback Share Copy URL https://www.pbs.org/newshour/show/promising-new-treatment-for-pancreatic-cancer-doubles-survival-rates Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter Audio A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research. The experimental drug, taken once a day, extends patients’ lives by slowing the progression of one of the deadliest cancers. Dr. Rachna Shroff, associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, joins Stephanie Sy for more. Listen to this Segment By — Stephanie Sy Stephanie Sy Stephanie Sy is a PBS News Hour correspondent. Throughout her career, she served in anchor and correspondent capacities for ABC News, Al Jazeera America, CBSN, CNN International, and PBS News Hour Weekend. Prior to joining News Hour, she was with Yahoo News where she anchored coverage of the 2018 Midterm Elections and reported from Donald Trump’s victory party on Election Day 2016. By — Karina Cuevas Karina Cuevas By — Katie Marlow Katie Marlow
Wow, thats great news! Doubling survival rates for pancreatic cancer could save countless lives. Lets celebrate this promising breakthrough and keep fighting for better treatments!
While doubling survival rates is a significant achievement, its crucial to remember that much more research and patient testing are needed to validate these results. Lets stay optimistic yet grounded.
Sounds like a game-changer! But remember, folks, its like when your mom tells you to eat your vegetablesjust because something looks promising doesnt mean itll work for everyone. Lets keep our fingers crossed and stay hopeful, but also be realistic. More research, more patients, more success stories. Together, we can beat this thing!
While exciting, we must remain skeptical. Cancer is complex; results must be replicated and thoroughly studied. Lets celebrate, but stay vigilant. #ScienceFirst
Absolutely! While its exciting, we should approach this with a healthy dose of skepticism. Lets not jump to conclusions just yetmore research is needed to see how it performs in real-world settings. Fingers crossed!